for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

ジョンソン・エンド・ジョンソン

JNJ.N

現在値

158.08USD

変化

2.15(+1.38%)

出来高

3,100,833

本日のレンジ

156.25

 - 

160.07

52週レンジ

145.90

 - 

179.91

∙ 約20分前の相場を表示しています。

適時開示

U.S. CDC Says Administered 462.3 Million Doses Of Covid-19 Vaccine As Of Dec 1

Dec 1 (Reuters) - U.S. CDC::U.S. CDC SAYS ADMINISTERED 462,263,845 DOSES OF COVID-19 VACCINE AS OF DEC 1 VERSUS 460,773,508 DOSES AS OF NOV 30.U.S. CDC SAYS DELIVERED 575,721,925 DOSES OF COVID-19 VACCINE AS OF DEC 1 VERSUS 573,238,255 DOSES AS OF NOV 30.U.S. CDC SAYS 233,590,555 INDIVIDUALS HAVE RECEIVED AT LEAST ONE DOSE OF COVID-19 VACCINE AS OF DEC 1 VERSUS 233,207,582 INDIVIDUALS AS OF NOV 30.U.S. CDC SAYS 197,363,116 INDIVIDUALS HAVE BEEN FULLY VACCINATED AGAINST COVID-19 AS OF DEC 1 VERSUS 197,058,988 INDIVIDUALS AS OF NOV 30.U.S. CDC SAYS AS OF DECEMBER 1, 41,933,410 PEOPLE RECEIVED A BOOSTER DOSE FOR COVID-19 VACCINE SINCE AUGUST 13, 2021. ((Reuters.Briefs@thomsonreuters.com;)).

FDA Approves New Kyprolis Combination Regimen With Darzalex Faspro And Dexamethasone

Dec 1 (Reuters) - Amgen Inc <AMGN.O>::FDA APPROVES NEW KYPROLIS® (CARFILZOMIB) COMBINATION REGIMEN WITH DARZALEX FASPRO® (DARATUMUMAB AND HYALURONIDASE-FIHJ) AND DEXAMETHASONE FOR PATIENTS WITH MULTIPLE MYELOMA AT FIRST OR SUBSEQUENT RELAPSE.

U.S. FDA Approves Darzalex Faspro In Combination With Carfilzomib And Dexamethasone

Dec 1 (Reuters) - Janssen: :U.S. FDA APPROVES DARZALEX FASPRO® (DARATUMUMAB AND HYALURONIDASE-FIHJ) IN COMBINATION WITH CARFILZOMIB AND DEXAMETHASONE FOR PATIENTS WITH MULTIPLE MYELOMA AFTER FIRST OR SUBSEQUENT RELAPSE.JANSSEN - APPROVAL OF DARZALEX FASPRO FOLLOWS REGULATORY SUBMISSION TO FDA IN FEBRUARY 2021.

S.Africa's Aspen Signs Term Sheet On Manufacture And Sale Of Aspen Branded COVID-19 Vaccine

Nov 30 (Reuters) - Aspen Pharmacare Holdings Ltd <APNJ.J>::JSE: APN - ASPEN CONFIRMS NON-BINDING TERM SHEET ON MANUFACTURE AND SALE OF AN ASPEN BRANDED COVID-19 VACCINE THROUGHOUT AFRICA.ASPEN PHARMACARE - ASPEN CAN SELL FINISHED FORM VACCINE UNDER ASPEN BRANDING TO PUBLIC SECTOR MARKETS IN AFRICA.ASPEN PHARMACARE - IN ADDITION, JOHNSON & JOHNSON WOULD GRANT ASPEN A LICENSE TO ENABLING INTELLECTUAL PROPERTY FOR THE PURPOSE.ASPEN PHARMACARE - ASPEN SA PLANS TO LAUNCH THIS VACCINE UNDER BRAND NAME "ASPENOVAX"..ASPEN - DEAL GRANTS ASPEN SA RIGHTS TO MANUFACTURE FINISHED SARS-COV-2 COVID-19 VACCINE PRODUCT FROM DRUG SUBSTANCE SUPPLIED BY JOHNSON & JOHNSON.ASPEN PHARMACARE - TERM OF GRANT OF RIGHTS AND SUPPLY OF DRUG SUBSTANCE, SUBJECT TO SIGNING OF DEFINITIVE AGREEMENT, WOULD BE UNTIL 31 DECEMBER 2026.JSE: APN - ASPEN CONFIRMS NON-BINDING TERM SHEET ON MANUFACTURE AND SALE OF AN ASPEN BRANDED COVID-19 VACCINE THROUGHOUT AFRICA.

U.S. CDC Says Delivered 572,190,175 Doses Of Covid-19 Vaccine As Of Nov 24 Versus 569,050,695 Doses Delivered As Of Nov 23

Nov 24 (Reuters) - U.S. CDC ::U.S. CDC SAYS DELIVERED 572,190,175 DOSES OF COVID-19 VACCINE AS OF NOV 24 VERSUS 569,050,695 DOSES DELIVERED AS OF NOV 23.U.S. CDC SAYS AS OF NOVEMBER 24, 37,499,004 PEOPLE RECEIVED A BOOSTER DOSE FOR COVID-19 VACCINE SINCE AUGUST 13, 2021.U.S. CDC SAYS ADMINISTERED 454,447,737 DOSES OF COVID-19 VACCINE AS OF NOV 24.U.S. CDC SAYS 231,367,686 INDIVIDUALS HAVE RECEIVED AT LEAST ONE DOSE OF COVID-19 VACCINE AS OF NOV 24 VERSUS 230,669,289 INDIVIDUALS AS OF NOV 23.U.S. CDC SAYS 196,168,756 INDIVIDUALS HAVE BEEN FULLY VACCINATED AGAINST COVID-19 AS OF NOV 24 VERSUS 195,973,992 INDIVIDUALS AS OF NOV 23. ((Reuters.Briefs@thomsonreuters.com;)).

Health Canada Announces Results Of Emergent Biosolutions Facility Inspection

Nov 24 (Reuters) - Health Canada: :HEALTH CANADA ANNOUNCES RESULTS OF EMERGENT BIOSOLUTIONS FACILITY INSPECTION.HEALTH CANADA - ALL THREE REGULATORS FOUND FACILITY TO BE COMPLIANT WITH GOOD MANUFACTURING PRACTICES.HEALTH CANADA - EUROPEAN MEDICINES AGENCY AND SOUTH AFRICAN HEALTH PRODUCTS REGULATORY AUTHORITY ALSO PARTICIPATED IN THIS INSPECTION REMOTELY.HEALTH CANADA - COMPLIANT RATING MEANS JANSSEN TO BE ABLE TO IMPORT THEIR VACCINES INTO CANADA MADE WITH DRUG SUBSTANCE MANUFACTURED AT EMERGENT'S FACILITY.

U.S. CDC Says Delivered 566,766,665 Doses Of Covid-19 Vaccine As Of Nov 22

Nov 22 (Reuters) - U.S. CDC::U.S. CDC SAYS DELIVERED 566,766,665 DOSES OF COVID-19 VACCINE AS OF NOV 22.U.S. CDC SAYS ADMINISTERED 452,657,967 DOSES OF COVID-19 VACCINE AS OF NOV 22 VERSUS 451,453,834 DOSES ADMINISTERED AS OF NOV 21.U.S. CDC SAYS 230,732,565 INDIVIDUALS HAVE RECEIVED AT LEAST ONE DOSE OF COVID-19 VACCINE AS OF NOV 22 VERSUS 230,298,744 INDIVIDUALS AS OF NOV 21.U.S. CDC SAYS 196,398,948 INDIVIDUALS HAVE BEEN FULLY VACCINATED AGAINST COVID-19 AS OF NOV 22 VERSUS 196,284,442 INDIVIDUALS AS OF NOV 21.U.S. CDC SAYS AS OF NOVEMBER 22, 36,058,472 PEOPLE RECEIVED A BOOSTER DOSE FOR COVID-19 VACCINE SINCE AUGUST 13, 2021. ((Reuters.Briefs@thomsonreuters.com;)).

EU Regulator Starts Evaluating Data On Booster Dose Of J&J's COVID-19 Vaccine

Nov 22 (Reuters) - European Medicines Agency::EMA: EMA EVALUATING DATA ON BOOSTER DOSE OF COVID-19 VACCINE JANSSEN: 22/11/2021.EMA SAYS EVALUATING AN APPLICATION FOR USE OF A BOOSTER DOSE OF COVID-19 VACCINE JANSSEN TO BE GIVEN AT LEAST TWO MONTHS AFTER FIRST DOSE TO PEOPLE.EMA - THE OUTCOME OF EVALUATION IS EXPECTED WITHIN WEEKS, UNLESS SUPPLEMENTARY INFORMATION IS NEEDED, AND WILL BE COMMUNICATED BY EMA..EMA SAYS OUTCOME OF THIS EVALUATION IS EXPECTED WITHIN WEEKS, UNLESS SUPPLEMENTARY INFORMATION IS NEEDED.EMA SAYS EVALUATING APPLICATION FOR USE OF A BOOSTER DOSE OF COVID-19 VACCINE JANSSEN TO PEOPLE AGED 18 YEARS AND OLDER.EMA: EMA'S HUMAN MEDICINES COMMITTEE (CHMP) WILL CARRY OUT AN ACCELERATED ASSESSMENT OF DATA SUBMITTED BY COMPANY THAT MARKETS VACCINE..EMA SAYS CHMP WILL RECOMMEND WHETHER UPDATES TO THE PRODUCT INFORMATION ARE APPROPRIATE.Further company coverage: JNJ.N. ((Reuters.Briefs@thomsonreuters.com;)).

U.S. CDC Says Delivered 562,868,095 Doses Of Covid-19 Vaccine As Of Nov 19

Nov 19 (Reuters) - U.S. CDC::U.S. CDC SAYS DELIVERED 562,868,095 DOSES OF COVID-19 VACCINE AS OF NOV 19 VERSUS 561,149,025 DOSES DELIVERED AS OF NOV 18.U.S. CDC SAYS ADMINISTERED 448,155,906 DOSES OF COVID-19 VACCINE AS OF NOV 19.U.S. CDC SAYS 229,291,004 INDIVIDUALS HAVE RECEIVED AT LEAST ONE DOSE OF COVID-19 VACCINE AS OF NOV 19.U.S. CDC SAYS 195,920,566 INDIVIDUALS HAVE BEEN FULLY VACCINATED AGAINST COVID-19 AS OF NOV 19 VERSUS 195,713,107 INDIVIDUALS AS OF NOV 18.U.S. CDC SAYS AS OF NOVEMBER 19, 33,454,832 PEOPLE RECEIVED A BOOSTER DOSE FOR COVID-19 VACCINE SINCE AUGUST 13, 2021. ((Reuters.Briefs@thomsonreuters.com;)).

U.S. CDC Says Delivered 561,149,025 Doses Of COVID-19 Vaccine As Of Nov 18

Nov 18 (Reuters) - :U.S. CDC SAYS DELIVERED 561,149,025 DOSES OF COVID-19 VACCINE AS OF NOV 18 VERSUS 558,460,315 DOSES DELIVERED AS OF NOV 17.U.S. CDC SAYS ADMINISTERED 446,250,342 DOSES OF COVID-19 VACCINE AS OF NOVEMBER 18 VERSUS 444,789,186 DOSES AS OF NOVEMBER 17.U.S. CDC SAYS 228,570,531 INDIVIDUALS HAVE RECEIVED AT LEAST ONE DOSE OF COVID-19 VACCINE AS OF NOV 18 VERSUS 228,175,638 INDIVIDUALS AS OF NOV 17.U.S. CDC SAYS 195,713,107 INDIVIDUALS HAVE BEEN FULLY VACCINATED AGAINST COVID-19 AS OF NOVEMBER 18 VERSUS 195,612,365 INDIVIDUALS AS OF NOVEMBER 17.U.S. CDC SAYS AS OF NOVEMBER 18, 32,469,881 PEOPLE RECEIVED A BOOSTER DOSE FOR COVID-19 VACCINE SINCE AUGUST 13, 2021.

金融情報はリフィニティブから。すべての情報は少なくとも20分遅れで表示されています。

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up